Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

SeaStar Medical Holding (ICUCW) Net Margin (2023 - 2025)

SeaStar Medical Holding's Net Margin history spans 3 years, with the latest figure at 752.33% for Q4 2025.

  • For Q4 2025, Net Margin rose 584319.0% year-over-year to 752.33%; the TTM value through Dec 2025 reached 1012.5%, up 1738009.0%, while the annual FY2025 figure was 1012.5%, 1738009.0% up from the prior year.
  • Net Margin reached 752.33% in Q4 2025 per ICUCW's latest filing, up from 1897.27% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 1638.8% in Q1 2023 to a low of 6595.52% in Q4 2024.
  • Average Net Margin over 3 years is 1872.97%, with a median of 1019.85% recorded in 2025.
  • The largest YoY upside for Net Margin was 584319bps in 2025 against a maximum downside of 468803bps in 2025.
  • A 3-year view of Net Margin shows it stood at 1087.56% in 2023, then tumbled by -706bps to 6595.52% in 2024, then soared by 89bps to 752.33% in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's Net Margin are 752.33% (Q4 2025), 1897.27% (Q3 2025), and 592.31% (Q2 2025).